145 related articles for article (PubMed ID: 16156457)
1. Low IGF-I in synovial fluid and serum in patients with aseptic prosthesis loosening.
Andersson MK; Stark A; Anissian L; Mohan S; Tsai JA
Acta Orthop; 2005 Jun; 76(3):320-5. PubMed ID: 16156457
[TBL] [Abstract][Full Text] [Related]
2. High levels of substance P and CGRP in pseudosynovial fluid from patients with aseptic loosening of their hip prosthesis.
Qian Y; Zeng BF; Zhang XL; Jiang Y
Acta Orthop; 2008 Jun; 79(3):342-5. PubMed ID: 18622837
[TBL] [Abstract][Full Text] [Related]
3. [Synovial fluid from aseptically failed total hip or knee arthroplasty is not toxic to osteoblasts].
Gallo J; Zdařilová A; Rajnochová Svobodová A; Ulrichová J; Radová L; Smižanský M
Acta Chir Orthop Traumatol Cech; 2010 Oct; 77(5):416-24. PubMed ID: 21040654
[TBL] [Abstract][Full Text] [Related]
4. Assessment of five interleukins in human synovial fluid as possible markers for aseptic loosening of hip arthroplasty.
Beraudi A; Stea S; Cremonini S; Visentin M; Toni A
Artif Organs; 2009 Jul; 33(7):538-43. PubMed ID: 19566730
[TBL] [Abstract][Full Text] [Related]
5. Concentration and size distribution of insulin-like growth factor-I in human normal and osteoarthritic synovial fluid and cartilage.
Schneiderman R; Rosenberg N; Hiss J; Lee P; Liu F; Hintz RL; Maroudas A
Arch Biochem Biophys; 1995 Dec; 324(1):173-88. PubMed ID: 7503553
[TBL] [Abstract][Full Text] [Related]
6. Tenascin-C levels in pseudosynovial fluid of loose hip prostheses.
Hasegawa M; Sudo A; Nagakura T; Hirata H; Kinoshita N; Yoshida T; Uchida A
Scand J Rheumatol; 2005; 34(6):464-8. PubMed ID: 16393770
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP proteases in human synovial fluid.
Matsumoto T; Gargosky SE; Iwasaki K; Rosenfeld RG
J Clin Endocrinol Metab; 1996 Jan; 81(1):150-5. PubMed ID: 8550744
[TBL] [Abstract][Full Text] [Related]
8. Serum interleukin 8 levels correlate with synovial fluid levels in patients with aseptic loosening of hip prosthesis.
Tanaka R; Yasunaga Y; Hisatome T; Yamasaki T; Iwamori H; Ochi M
J Arthroplasty; 2005 Dec; 20(8):1049-54. PubMed ID: 16376262
[TBL] [Abstract][Full Text] [Related]
9. High macrophage-colony stimulating factor levels in synovial fluid of loose artificial hip joints.
Takei I; Takagi M; Ida H; Ogino T; Santavirta S; Konttinen YT
J Rheumatol; 2000 Apr; 27(4):894-9. PubMed ID: 10782812
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein (IGFBP)-3 levels in Arab subjects with coronary heart disease.
Akanji AO; Suresh CG; Al-Radwan R; Fatania HR
Scand J Clin Lab Invest; 2007; 67(5):553-9. PubMed ID: 17763192
[TBL] [Abstract][Full Text] [Related]
11. Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro.
Schlenska-Lange A; Knüpfer H; Lange TJ; Kiess W; Knüpfer M
Anticancer Res; 2008; 28(2A):1055-60. PubMed ID: 18507054
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-II (IGF-II), IGF-binding protein-3 (IGFBP-3), and IGFBP-4 in follicular fluid are associated with oocyte maturation and embryo development.
Wang TH; Chang CL; Wu HM; Chiu YM; Chen CK; Wang HS
Fertil Steril; 2006 Nov; 86(5):1392-401. PubMed ID: 17070193
[TBL] [Abstract][Full Text] [Related]
13. [Cytokines and bone turnover markers].
Odrowaz-Sypniewska G; Lis K; Biliński PJ
Przegl Epidemiol; 2002; 56 Suppl 4():39-45. PubMed ID: 14750259
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal inflammation and the circulating IGF system in humans.
Baricević I; Jones DR; Nikolić JA; Nedić O
Horm Metab Res; 2006 Jan; 38(1):22-7. PubMed ID: 16477536
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory response in 85 patients with loosened hip prostheses: a prospective study comparing inflammatory markers in patients with aseptic and septic prosthetic loosening.
Nilsdotter-Augustinsson A; Briheim G; Herder A; Ljunghusen O; Wahlström O; Ohman L
Acta Orthop; 2007 Oct; 78(5):629-39. PubMed ID: 17966022
[TBL] [Abstract][Full Text] [Related]
16. Bone turnover markers and cytokines in joint fluid: analyses in 10 patients with loose hip prosthesis and 39 with coxarthrosis.
Sypniewska G; Lis K; Bilinski PJ
Acta Orthop Scand; 2002 Oct; 73(5):518-22. PubMed ID: 12440494
[TBL] [Abstract][Full Text] [Related]
17. The role of reactive oxygen species scavenging enzymes in the development of septic loosening after total hip replacement.
Peng KT; Hsu WH; Shih HN; Hsieh CW; Huang TW; Hsu RW; Chang PJ
J Bone Joint Surg Br; 2011 Sep; 93(9):1201-9. PubMed ID: 21911531
[TBL] [Abstract][Full Text] [Related]
18. Patient-related risk factors leading to aseptic stem loosening in total hip arthroplasty: a case-control study of 5,035 patients.
Münger P; Röder C; Ackermann-Liebrich U; Busato A
Acta Orthop; 2006 Aug; 77(4):567-74. PubMed ID: 16929432
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of IGF-1 concentration in serum and synovial fluid in women with different type coxarthrosis].
Lis K; Odrowaz-Sypniewska G; Nowacki W
Chir Narzadow Ruchu Ortop Pol; 2005; 70(6):407-10. PubMed ID: 16875181
[TBL] [Abstract][Full Text] [Related]
20. Alteration of the insulin-like growth factor axis during in vitro differentiation of the human osteosarcoma cell line HOS 58.
Viereck V; Siggelkow H; Pannem R; Braulke T; Scharf JG; Kübler B
J Cell Biochem; 2007 Sep; 102(1):28-40. PubMed ID: 17372931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
